PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > Formulary Search > PAD Profile : Bilastine - Allergic rhinitis
PAD Profile : Bilastine - Allergic rhinitis
Keywords :
Hay fever, hayfever, antihistamines, allergy, seasonal allergic rhinitis, pollen allergy, non-sedating antihistamines
Brand Names Include :
Ilaxten
Traffic Light Status
Status 1 of 1.
Guidelines
The following guidelines are available for this indication.
Other Drugs
- Cetirizine hydrochloride
- Loratadine
- Desloratadine
- Levocetirizine
- Mizolastine
- Acrivastine
- Rupatadine fumarate
- House dust mites allergen extract
- White Birch pollen allergen extract
Other Indications
No indications returned.
Additional Documents
Type
Document
Review Date
Committee Recommendations
Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)
Bilastine tablets for allergic rhinitis have not been recommended for use within the local guidelines.
Bilastine is considerably more expensive and is not considered a cost-effective treatment option.
Associated BNF Codes
03. Respiratory System
03.04.01. Antihistamines